NCT07113808Recruiting
Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
Clinical Medical Quality Control Management of Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China: A Multi-Center Study
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the application of intravenous contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses. The main questions it aims to answer are: * Is intravenous contrast-enhanced ultrasound helpful for the diagnosis of intra-abdominal diseases in children? * What medical problems do participants have when participating in intravenous contrast-enhanced ultrasound examination? * How can ultrasound doctors conduct intravenous contrast-enhanced ultrasound examinations in a standardized manner? Researchers will performing intravenous contrast-enhanced ultrasound examinations on participants and collecting research subjects to establish a multicenter clinical data database. Participants will: * Perform abdominal ultrasound examination to assess the condition. * At least conduct one intravenous contrast-enhanced ultrasound examination. Based on the result of the contrast examination, decide whether to conduct another examination. * Keep a diary of their symptoms and therapeutic process in 30 days.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 108 (estimated)
- First submitted
- 17 Jul 2025
- Start date
- 10 Sept 2024
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Diseases
- Childhood cancers
- NCT number
- NCT07113808
What you commit to
- Study type: Observational
- Planned participants: 108
- From 10 Sept 2024 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergic to sulfur hexafluoride or other components;
- Heart disease with right-to-left shunt/severe pulmonary hypertension /uncontrolled systemic hypertension/respiratory failure/heart failure/severe arrhythmia;
- Electrocardiogram, echocardiography or clinical manifestations of myocardial ischemia;
- Patients with severe blood system diseases or infectious diseases;
- Hypercoagulable state and recent history of thrombosis;
- Severe hepatic and renal insufficiency;
- Patients with respiratory tract infection or congenital respiratory malformation.
Who the study is looking for
- Age 29 days to 18 years old;
- The clinical diagnosis was abdominal space-occupying lesions, blunt abdominal trauma, ascites of unknown cause, and children with suspected abdominal disease but other examinations could not identify the cause.
Age in the registry: 29 days to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital, Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.